HIMS & HERS HEALTH, INC. vs Privia Health Group, Inc., two Medical Services stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Neither telehealth-era operator earns much on capital yet, and the small differences tell: Privia earns a positive 2.7% on equity coordinating physician groups, Hims a negative 3% selling direct-to-consumer treatments, though Hims' loss is nearly break-even at the net line, negative 0.6%. The models split at gross margin, 65.3% at Hims, retail pharmacy economics with a brand attached, against Privia's undisclosed but structurally thin practice-management take. Neither carries debt; neither has a usable multiple. Free cash favors Privia, 4.1% against 0.8%. Two routes into care delivery, consumer brand against physician platform, both priced on subscriber and panel growth the fundamentals page can only imply.
Comparison updated 2026-07-10.
| Metric | HIMS | PRVA |
|---|---|---|
| Price | $33.87 | $25.55 |
| Market cap | $7.7B | $3.3B |
| Sector | Medical Services | Medical Services |
| Stage | Growth | Growth |
| P/B | 17.34 | 4.15 |
| P/S | 3.26 | 1.49 |
| EV/EBITDA | 118.1 | 61.3 |
| Revenue growth | +38.5% | +24.8% |
| Gross margin | 65.3% | — |
| Operating margin | -12.9% | 1.2% |
| Net margin | -0.6% | 1.0% |
| Return on equity | -3.0% | 2.7% |
| Return on assets | -0.6% | 1.5% |
| Return on invested capital | 7.4% | 3.6% |
| FCF yield | 0.8% | 4.1% |
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 1.69 | 1.61 |
| Altman Z (solvency) | 3.58 | 5.04 |
| Piotroski F (quality) | 4 / 9 | 5 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.